Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4590512 | 0.89 | TSHR (0.40) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL3234096 | 0.88 | TSHR (0.50) | TSHRHPGDTHRBALDH1A1TP53 | |
| SCHEMBL3243172 | 0.86 | TSHR (0.48) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL28613126 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL7787871 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL28723996 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL28653260 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL28595219 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL20842347 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 | |
| SCHEMBL28708590 | 0.85 | TSHR (0.47) | TSHRHPGDTHRBALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118486813-B | Polymer coated graphite negative electrode material and preparation method and application thereof | 深圳市贝特瑞新能源技术研究院有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-118486813-A | Polymer coated graphite negative electrode material and preparation method and application thereof | 深圳市贝特瑞新能源技术研究院有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-118048192-A | Modified methanol fuel for compression ignition type internal combustion engine and preparation process thereof | 闳然(重庆)新能源技术开发有限公司 | 2024-05-17 | — | — | CN | claimed |
| EP-3390535-B1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-05-24 | — | — | EP | claimed |
| US-20190169339-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-06-06 | — | — | US | claimed |
| EP-3417008-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC Global Technologies B.V. (NL) | 2018-12-26 | — | — | EP | claimed |
| EP-3390535-A1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC Global Technologies B.V. (NL) | 2018-10-24 | — | — | EP | claimed |
| CN-108495892-A | Method for producing polyformaldehyde injection molding object | SABIC环球技术有限责任公司 | 2018-09-04 | — | — | CN | claimed |
| WO-2017162393-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-09-28 | — | — | WO | claimed |
| WO-2017102233-A1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-22 | — | — | WO | claimed |
| US-6136896-A | Graft copolymers containing polydiorganosiloxane and polybutylene grafts | DOW CORNING CORPORATION (US) | 2000-10-24 | — | — | US | claimed |
| US-20260092206-A1 | RELEASE COATING COMPOSITIONS FOR ADHESIVE TAPE AND METHODS | INTERTAPE POLYMER CORP. (US) | 2026-04-02 | — | — | US | disclosed |
| EP-4709806-A2 | RELEASE COATING COMPOSITIONS FOR ADHESIVE TAPE AND METHODS | Intertape Polymer Corp. (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12486384-B2 | Latex composition and dip-molded body | ZEON CORPORATION (JP) | 2025-12-02 | — | — | US | disclosed |
| CN-112602022-B | Toner for developing electrostatic image | 日本瑞翁株式会社 | 2025-02-14 | — | — | CN | disclosed |
| WO-1996000562-A1 | PERSONAL CARE COMPOSITIONS CONTAINING THERMOPLASTIC ELASTOMERIC GRAFT COPOLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-01-11 | — | — | WO | disclosed |
| US-5356968-A | Free radical polymerization mixture containing anionic emulsifier | BASF AKTIENGESELLSCHAFT (DE) | 1994-10-18 | — | — | US | disclosed |
| US-5340876-A | Comprising styrenes, (meth)acrylonitrile and acrylate monomers with rubbers | BAYER AKTIENGESELLSCHAFT (DE) | 1994-08-23 | — | — | US | disclosed |
| US-5122571-A | MOULDING COMPOUNDS OF POLYAMIDES AND GRAFT POLYMERS CONTAINING TERT.-BUTYLACRYLATE | BAYER AKTIENGESELLSCHAFT (DE) | 1992-06-16 | — | — | US | disclosed |
| EP-0290771-A2 | Small particle size surface active protective colloid-stabilized latexes derived from monomers of high aqueous phase grafting tendencies | HERCULES INCORPORATED (US) | 1988-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092206-A1 | RELEASE COATING COMPOSITIONS FOR ADHESIVE TAPE AND METHODS | RAD23B, ALKBH2, ALKBH3 | TSHR 427/4885HPGD 4010/4885THRB 652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.